Wonder

Research Outline

Prepared for Jay G. | Delivered August 3, 2020

Sim & Cure Overview

Goals

To provide an overview of Sim & Cure, including market opportunity, user journey through the service, key-value pools, competitors they may exist, overall product features, if the company is solving the stakeholder needs, and an overview of the interventional neuroradiology surgical planning process.

Early Findings

Sim & Cure - OverviewSim & Cure is a software development company that aids in planning endovascular treatment and optimizing medical devices. 
Its trademark product, Sim&Size™ is a certified CE mark Class IIa and ISO 13485 certified software.
The software is cleared by the FDA.
ValuesAccording to the company's CEO, Sim & Cure strives to "offer products and services that deliver clinical and economic value to healthcare consumers and providers around the world."
Market OpportunitySim & Cure targets the neurovascular device market which is worth €3 billion in 2020. Growth in the
 neurovascular market comes from an "increasing number of potential patients for hemorrhagic stroke (2.5m/year) and an 85% prevalence of cerebral aneurysm among the strokes."
CompetitorsAccording to Craft, top competitors of Sim & Cure include OtoNexus Medical Technologies, Inc., iHear Medical
, Resound, and Rewalk Robotics.